Cargando…
Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
Orthotopic allograft transplantation (OAT) is a major strategy for solid heart and kidney failure. However, the recipient’s immunity-induced chronic rejection induces OAT vasculopathy that results in donor organ failure. With the exception of immunosuppressive agents, there are currently no specific...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139124/ https://www.ncbi.nlm.nih.gov/pubmed/35625826 http://dx.doi.org/10.3390/biomedicines10051089 |
_version_ | 1784714785523236864 |
---|---|
author | Lin, Yi-Wen Tsai, Chien-Sung Huang, Chun-Yao Tsai, Yi-Ting Shih, Chun-Ming Lin, Shing-Jong Li, Chi-Yuan Lin, Cheng-Yen Sung, Shih-Ying Lin, Feng-Yen |
author_facet | Lin, Yi-Wen Tsai, Chien-Sung Huang, Chun-Yao Tsai, Yi-Ting Shih, Chun-Ming Lin, Shing-Jong Li, Chi-Yuan Lin, Cheng-Yen Sung, Shih-Ying Lin, Feng-Yen |
author_sort | Lin, Yi-Wen |
collection | PubMed |
description | Orthotopic allograft transplantation (OAT) is a major strategy for solid heart and kidney failure. However, the recipient’s immunity-induced chronic rejection induces OAT vasculopathy that results in donor organ failure. With the exception of immunosuppressive agents, there are currently no specific means to inhibit the occurrence of OAT vasculopathy. On the other hand, far-infrared (FIR) therapy uses low-power electromagnetic waves given by FIR, with a wavelength of 3–25 μm, to improve human physiological functions. Previous studies have shown that FIR therapy can effectively inhibit inflammation. It has also been widely used in adjuvant therapy for various clinical diseases, especially cardiovascular diseases, in recent years. Thus, we used this study to explore the feasibility of FIR in preventing OAT vasculopathy. In this study, the model of transplantation of an aorta graft from PVG/Seac rat to ACI/NKyo rat, and in vitro model of human endothelial progenitor cells (EPCs) was used. In this report, we presented that FIR therapy decreased the serious of vasculopathy in OAT-recipient ACI/NKyo rats via inhibiting proliferation of smooth muscle cells, accumulation of collagen, and infiltration of fibroblast in the vessel wall; humoral and cell-mediated immune responses were decreased in the spleen. The production of inflammatory proteins/cytokines also decreased in the plasma. Additionally, FIR therapy presented higher mobilization and circulating EPC levels associated with vessel repair in OAT-recipient ACI/NKyo rats. In vitro studies demonstrated that the underlying mechanisms of FIR therapy inhibiting OAT vasculopathy may be associated with the inhibition of the Smad2-Slug axis endothelial mesenchymal transition (EndoMT). Thus, FIR therapy may be the strategy to prevent chronic rejection-induced vasculopathy. |
format | Online Article Text |
id | pubmed-9139124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91391242022-05-28 Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy Lin, Yi-Wen Tsai, Chien-Sung Huang, Chun-Yao Tsai, Yi-Ting Shih, Chun-Ming Lin, Shing-Jong Li, Chi-Yuan Lin, Cheng-Yen Sung, Shih-Ying Lin, Feng-Yen Biomedicines Article Orthotopic allograft transplantation (OAT) is a major strategy for solid heart and kidney failure. However, the recipient’s immunity-induced chronic rejection induces OAT vasculopathy that results in donor organ failure. With the exception of immunosuppressive agents, there are currently no specific means to inhibit the occurrence of OAT vasculopathy. On the other hand, far-infrared (FIR) therapy uses low-power electromagnetic waves given by FIR, with a wavelength of 3–25 μm, to improve human physiological functions. Previous studies have shown that FIR therapy can effectively inhibit inflammation. It has also been widely used in adjuvant therapy for various clinical diseases, especially cardiovascular diseases, in recent years. Thus, we used this study to explore the feasibility of FIR in preventing OAT vasculopathy. In this study, the model of transplantation of an aorta graft from PVG/Seac rat to ACI/NKyo rat, and in vitro model of human endothelial progenitor cells (EPCs) was used. In this report, we presented that FIR therapy decreased the serious of vasculopathy in OAT-recipient ACI/NKyo rats via inhibiting proliferation of smooth muscle cells, accumulation of collagen, and infiltration of fibroblast in the vessel wall; humoral and cell-mediated immune responses were decreased in the spleen. The production of inflammatory proteins/cytokines also decreased in the plasma. Additionally, FIR therapy presented higher mobilization and circulating EPC levels associated with vessel repair in OAT-recipient ACI/NKyo rats. In vitro studies demonstrated that the underlying mechanisms of FIR therapy inhibiting OAT vasculopathy may be associated with the inhibition of the Smad2-Slug axis endothelial mesenchymal transition (EndoMT). Thus, FIR therapy may be the strategy to prevent chronic rejection-induced vasculopathy. MDPI 2022-05-07 /pmc/articles/PMC9139124/ /pubmed/35625826 http://dx.doi.org/10.3390/biomedicines10051089 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lin, Yi-Wen Tsai, Chien-Sung Huang, Chun-Yao Tsai, Yi-Ting Shih, Chun-Ming Lin, Shing-Jong Li, Chi-Yuan Lin, Cheng-Yen Sung, Shih-Ying Lin, Feng-Yen Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy |
title | Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy |
title_full | Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy |
title_fullStr | Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy |
title_full_unstemmed | Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy |
title_short | Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy |
title_sort | far-infrared therapy decreases orthotopic allograft transplantation vasculopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139124/ https://www.ncbi.nlm.nih.gov/pubmed/35625826 http://dx.doi.org/10.3390/biomedicines10051089 |
work_keys_str_mv | AT linyiwen farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT tsaichiensung farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT huangchunyao farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT tsaiyiting farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT shihchunming farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT linshingjong farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT lichiyuan farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT linchengyen farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT sungshihying farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy AT linfengyen farinfraredtherapydecreasesorthotopicallografttransplantationvasculopathy |